Vident Advisory’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$876K Buy
9,683
+3,456
+56% +$317K 0.01% 937
2025
Q4
$560K Sell
6,227
-1,637
-21% -$155K 0.01% 1111
2025
Q3
$775K Sell
7,864
-285
-3% -$28.2K 0.01% 955
2025
Q2
$743K Sell
8,149
-5,939
-42% -$574K 0.01% 860
2025
Q1
$1.59M Buy
14,088
+7,099
+102% +$759K 0.02% 557
2024
Q4
$738K Buy
6,989
+48
+0.7% +$5.15K 0.01% 773
2024
Q3
$749K Buy
6,941
+1,503
+28% +$164K 0.02% 739
2024
Q2
$590K Buy
5,438
+1,036
+24% +$122K 0.02% 799
2024
Q1
$581K Buy
4,402
+10
+0.2% +$1.25K 0.01% 767
2023
Q4
$535K Buy
4,392
+266
+6% +$29.7K 0.01% 759
2023
Q3
$463K Buy
+4,126
New +$524K 0.01% 728

Other funds holding ZBH

Vident Advisory's ZBH Position: Q1 2026 in Review

Vident Advisory increased its Zimmer Biomet (ZBH) stake by 56% in Q1 2026, buying an estimated $317K and bringing the position to 9,683 shares worth $876K. The position accounts for 0.01% of the portfolio, ranked #937.

Vident Advisory first reported a position in ZBH in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.59M in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Vident Advisory held 9,683 shares of Zimmer Biomet worth $876K as of Q1 2026.
  • Vident Advisory bought 3,456 Zimmer Biomet shares in Q1 2026, an estimated $317K.
  • Zimmer Biomet made up 0.01% of Vident Advisory's portfolio in Q1 2026, its #937 holding.
  • Vident Advisory first reported a position in Zimmer Biomet in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's Zimmer Biomet position peaked at $1.59M in Q1 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.